Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Molecular Psychiatry|May 2, 2015
A systematic review of agomelatine-induced liver injurySilka Dawn Freiesleben, Karolina Furczyk
BMC Geriatrics|June 22, 2021
Overcoming barriers to the adoption of locating technologies in dementia care: a multi-stakeholder focus group studySilka Dawn Freiesleben, Herlind Megges, Christina Herrmann, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Technology for home dementia care: A prototype locating system put to the testHerlind Megges, Silka Dawn Freiesleben, Natalie Jankowski, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|August 24, 2021
Presenilin 1 Gene Mutation (M139V) in a German Family with Early-Onset Alzheimer's Disease: A Case ReportManuel Fuentes, Carola G Schipke, Silka Dawn Freiesleben, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 7, 2018
User experience and clinical effectiveness with two wearable global positioning system devices in home dementia careHerlind Megges, Silka Dawn Freiesleben, Christina Rösch, et al.
Journal of Alzheimer'S Disease : JAD|October 19, 2020
Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease ContinuumFelix Menne, Carola Gertrud Schipke, Arne Klostermann, et al.
Neuroimage|September 1, 2019
The hippocampal-to-ventricle ratio (HVR): Presentation of a manual segmentation protocol and preliminary evidenceDorothee Schoemaker, Claudia Buss, Sandra Pietrantonio, et al.
Journal of Cognitive Neuroscience|July 7, 2026
Diagnostic Images for Mild Cognitive Impairment Are Sensitive to Alzheimer's Disease Biomarkers and Reveal Abnormal Scene ProcessingYuetong Bai, Oliver Peters, Silka Dawn Freiesleben, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2024
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired IndividualsLena Sannemann, Claudia Bartels, Frederic Brosseron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression riskLuisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, et al.
Pageof 3